Nutrition-Related Cardiovascular Risk Factors in Hemodialysis Patients

Journal of Renal Nutrition

Volumn 20, Issue 3, 2010, Pages 185-192

  Arslan, Yasemin ^a   Kiziltan, Gul ^a  

^a BASKENT UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; SERUM ALBUMIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CROSS-SECTIONAL STUDY; DIET; FAT INTAKE; FEMALE; HUMAN; MALE; MIDDLE AGED; NUTRITIONAL STATUS; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIET; DIETARY FATS; FEMALE; FOLIC ACID; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; QUESTIONNAIRES; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; VITAMIN B 12;

EID: 77950928654     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2009.08.008     Document Type: Article

References (60)

1. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
2. United States Renal Data System. USRDS 2007 Annual Report: Atlas of End-Stage Renal Disease in United States (2007), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. available at www.usrds.org/adr.htm
3. Turkish Society of Nephrology: Registry of Nephrology, Dialysis and Transplantation in Turkey. Available at http//:www.tsn.org.tr/documents/registry/registry_2007_tr-eng.pdf
4. Lindner A., Charra B., Sherrerd D.J., et al. Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290 (1974) 697-701
5. Raine A.E.G., Schwarz U., and Ritz E. The patient with uremia: hypertension and cardiac problems. In: Davison A.M. (Ed). Oxford Textbook of Clinical Nephrology (1998), Oxford University Press, Oxford 1885-1919
6. Wheeler D.C. Cardiovascular complications of chronic kidney disease. Medicine (Baltimore) 35 (2007) 453-456
7. United States Renal Data System. USRDS 2003 Annual Report: Atlas of End-Stage Renal Disease in United States (2003), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Available at www.usrds.org/adr.htm
8. United States Renal Data System. USRDS 2004 Annual Report: Atlas of End-Stage Renal Disease in United States (2004), National Institutes of Health. National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Available at www.usrds.org/adr.htm
9. Go A.S., Chertow G.M., Fan D., et al. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 351 (2004) 1296-1305
10. Weiner D.E., Tabatabai S., Tighiourart H., et al. Cardiovascular outcomes and all-cause mortality: exploring the interaction between CKD and cardiovascular disease. Am J Kidney Dis 48 (2006) 392-401
11. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Asssocition Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
12. Fort J. Chronic renal failure: a cardiovascular risk factor. Kidney Int 68 Suppl 99 (2005) S25-S29
13. Al-Ahmod A., Rand W.M., Manjunath G., et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38 (2001) 955-962
14. Garesh S.K., Stack A.G., Levin N.W., et al. Association of elevated serum PO(4), Cax(PO(4)) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12 (2001) 2131-2138
15. Qureshi A.R., Alvestrand A., Divino-Filho J.C., et al. Inflammation, malnutrition and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13 Suppl (2002) S28-S36
16. Krauss R.M., Eckel R.H., Howard B., et al. AHA dietary guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102 (2000) 2296-2311
17. Cupisti A., D'Allessandro C., Baldi R., et al. Dietary habits and counseling focused on phosphate intake in hemodialysis patients with hyperphosphatemia. J Ren Nutr 14 (2004) 220-225
18. Wiggins K.L., and Harvey K.S. A review of guidelines for nutrition care of renal patients. J Ren Nutr 12 (2002) 190-196
19. World Health Organization. Technical Report Series: Diet, Nutrition and the Prevention of Chronic Diseases (2003), World Health Organization, Geneva
20. Detsky A.S., Mclaugghlin J.R., and Baker J.P. What is subjective global assessment of nutritional status?. J Parenter Enteral Nutr 11 (1987) 8-13
21. Enia G., Sicuso C., and Alati G. Subjective global assessment of nutrition in dialysis patients. Nephrol Dial Transplant 8 (1993) 1094-1098
22. Kalantar-Zadeh K., Kleiner M., Dunne E., et al. Total binding capacity-estimated transferring concentrations in dialysis patients correlate with the subjective global assessment of nutrition. Am J Kidney Dis 31 (1998) 263-272
23. Kalantar-Zadeh K., Kleiner M., Dunne E., et al. A modified quantitive subjective global assessment of nutrition for dialysis patients. Nephrol Dial Transplant 14 (1999) 1732-1738
24. National Kidney Foundation. K/DOQI. Clinical Practice Guidelines for nutrition in chronic renal failure. Am J Kidney Dis 35 Suppl 2 (2000) 6
25. Cano N., Fiaccadori E., Tesinsky P., et al. ESPEN guidelines on enteral nutrition: adult renal failure. Clin Nutr 25 (2006) 295-310
26. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 6 (1972) 499-502
27. Clarke R., Evans G., Schneede J., et al. Vitamin B12 and folate deficiency in later life. Age Ageing 33 (2004) 34-41
28. Ueland P.M., Refsum U., Stabler S.P., et al. Total homocysteine in plasma and serum: methods and clinical applications. Clin Chem 39 (1993) 1767-1779
29. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin Dial 16 (2003) 101-105
30. Lippi G., Tessitore N., Gammore L., et al. Cardiovascular risk factors in patients with chronic renal failure maintained on hemodialysis or continuous ambulatory peritoneal dialysis. Thromb Res 101 (2001) 517-519
31. Wanner C., and Quaschning T. Dyslipidemia and renal disease: pathogenesis and clinical consequences. Curr Opin Nephrol Hypertens 10 (2001) 195-201
32. Cofan F., Vela E., and Cleris M. Analysis of dyslipidemia in patients on chronic hemodialysis in Catalonia. Atherosclerosis 184 (2006) 94-102
33. Hurselman M., Moosa M.R., Kotze T.J., et al. Protein-energy malnutrition as a risk factor increased morbidity in long-term hemodialysis patients. J Ren Nutr 10 (2000) 7-15
34. Burrowes J.D., Dalton S., Backstrand J., et al. Patients receiving maintenance hemodialysis with low vs high levels of nutritional risk have decreased morbidity. J Am Diet Assoc 105 (2005) 563-572
35. Beddhu S., Pappas L.M., Ramkumar N., et al. Malnutrition and atherosclerosis in dialysis patients. J Am Soc Nephrol 15 (2004) 733-742
36. Chazot C., Laurant G., Bernard C., et al. Malnutrition in Long-term hemodialysis survivors. Nephrol Dial Transplant 16 (2001) 60-69
37. Jones C.H., Wolfenden R.C., and Wells L.M. Is subjective global assessment a reliable measure of nutritional status in hemodialysis?. J Ren Nutr 14 (2004) 26-30
38. Jane L. Prevalence and prognostic significance of malnutrition in chronic renal insufficiency in hemodialysis. J Ren Nutr 11 (2001) 16-22
39. Lowrie E.G., and Lew N.L. Commonly measured laboratory variables in hemodialysis patients. Relationship among them and to death risk. Semin Nephrol 12 (1992) 276-283
40. Basille C. The effect of convention on the nutritional status of haemodialysis patients. Nephrol Dial Transplant 18 (2003) 46-49
41. Leavey S.F., Strawderman R.L., Jones C.A., et al. Simple nutritional indicators as independent predictors of mortality in hemodialysis patients. Am J Kidney Dis 31 (1998) 997-1006
42. Kalantar-Zadeh K., Block G., Humphreys M.H., et al. Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int 63 (2003) 793-808
43. Beddhu S. The body mass index paradox and an obesity, inflammation and atherosclerosis syndrome in chronic kidney disease. Semin Dial 17 (2004) 229-232
44. Hakim R.M., and Lowrie E. Obesity and mortality in ESRD: is it good to be fat?. Kidney Int 55 (1999) 1580-1581
45. Kramer H.J., Saranathan A., Luke A., et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol 17 (2006) 1453-1459
46. Leavey S.F., McCullough K.M., Hecking E., et al. Body mass index and mortality in "healthier" as compared with "sicker" haemodialysis patients: results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephrol Dial Transplant 16 (2001) 2386-2394
47. Vlagopoulos P.T., Tighiouart H., Weiner D.E., et al. Anemia as a risk factor for cardiovascular disease and all-cause mortality in diabetes: the impact of chronic kidney disease. J Am Soc Nephrol 16 (2005) 3403-3410
48. Clarke R., Daly L., Robinson K., et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324 (1991) 1149-1155
49. Nerbass F.B., Draibe S.A., Feiten S.F., et al. Homocysteine and its determinants in nondialyzed chronic kidney disease patients. J Am Diet Assoc 106 (2006) 267-270
50. Friedman A.N., Bostom A.G., Selhub J., et al. The kidney and homocysteine metabolism. J Am Soc Nephrol 12 (2001) 2181-2189
51. Bostom A.G., and Culleton B.F. Hyperhomocysteinemia in chronic renal disease. J Am Soc Nephrol 10 (1999) 891-900
52. Moustapha A., Naso A., Nahlawi M., et al. Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97 (1998) 138-141
53. Bostom A.G., and Lathrop L. Hyperhomocysteinemia in end-stage renal disease: prevalence, etiology and potential relationship to atherosclerotic outcomes. Kidney Int 52 (1997) 10-20
54. Lindner A., Bankson D.D., Stehman-Breen S., et al. Vitamin B6 metabolism and homocysteine in end-stage renal disease and chronic renal insufficiency. Am J Kidney Dis 39 (2002) 134-145
55. Elian K.M., and Hoffer L.J. Hydroxocobalamin reduces hyperhomocysteinemia in end-stage renal disease. Metabolism 51 (2002) 881-886
56. Koyama K., Usami T., Takeuchi O., et al. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in hemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 17 (2002) 916-922
57. Wrone E.M., Hornberger J.M., Zehnder J.L., et al. Randomized trial of folic acid for prevention of cardiovascular events in end-stage renal disease. J Am Soc Nephrol 15 (2004) 420-426
58. Kalantar-Zadeh K., İkizler T.A., Block G., et al. Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis 42 (2003) 864-881
59. Stenvinkel P., Heimbürger O., Lindholm B., et al. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis. Nephrol Dial Transplant 15 (2000) 953-960
60. Locatelli F., Fouque D., Heimburger O., et al. Nutritional status in dialysis patients: a European consensus. Nephrol Dial Transplant 17 (2002) 563-572